Similarly, Kopecka et al. reported that CA XII expression increased during the acquisition of chemoresistance in colorectal cancer cells and that chemosensitivity could be restored by pharmacological inhibition of CA XII.19 This evidence concerns the gene CA12 and colorectal cancer.